ArticleNAR cancer2021

A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.

Muhammad Sohail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.